[Road safety under psychiatric drug targeting].
Fachkrankenhaus für Psychiatrie, Psychotherapie, Psychosomatische Medizin und Neurologie, Akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität München. alexander.brunnauer@inn-salzach-klinikum.de
A
A
Brunnauer
G
G
Laux
D000063:Accidents, Traffic / Q000706:statistics & numerical data; D000928:Antidepressive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001334:Automobile Driving; D002492:Central Nervous System Depressants / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D003198:Computer Simulation; D000431:Ethanol / Q000009:adverse effects; D005062:European Union; D005858:Germany / Q000453:epidemiology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D001523:Mental Disorders / Q000188:drug therapy / Q000523:psychology; D011619:Psychotropic Drugs / Q000009:adverse effects*; D014149:Tranquilizing Agents / Q000009:adverse effects
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002492:Central Nervous System Depressants; D000697:Central Nervous System Stimulants; D006993:Hypnotics and Sedatives; D011619:Psychotropic Drugs; D014149:Tranquilizing Agents; D000431:Ethanol